Boehringer Ingelheim Aservo Equihaler now recyclable

Aservo Equihaler is the first approved inhaled glucocorticoid treatment for horses with severe equine asthma. It is made from up to 50% recycled materials and can now be recycled through a collaboration with TerraCycle, said Amanda McAvoy, US Equine Business Manager. . Photo courtesy of Boehringer Ingelheim

In its ongoing commitment to global sustainability, Boehringer Ingelheim has partnered with international recycling leader TerraCycle® to create a recycling program for Aservo® Equihaler® (ciclesonide inhalation aerosol). Aservo Equihaler is the world’s first approved inhaled glucocorticoid treatment for horses with severe equine asthma. This program will ensure that the device does not contribute to the growing problem of overcrowded landfills. As an added incentive, for every Aservo Equihaler device returned to TerraCycle, shippers can earn points that can be donated to a nonprofit, school, or charity of their choice.

Participation in the program is free and simple. Veterinarians and horse owners register on:
https://www.terracycle.com/en-CA/brigades/equihaler, download the prepaid shipping label, affix the label to any box and ship the empty Aservo Equihaler to TerraCycle. Once collected, the plastic material is melted, granulated and shaped into hard plastic to be used in the creation of new products such as shipping pallets and park benches.

The Aservo Equihaler is designed for a one-time use of 10 days, so it is important to be part of a recycling process. “This product brings great innovation to the equine industry for several reasons,” said Amanda McAvoy, USA Equine Business Manager. “This is the first inhaled glucocorticoid treatment approved for horses with severe equine asthma, it is made from up to 50% recycled materials and can now be recycled thanks to this collaboration with TerraCycle. We are proud to continue to be part of the team dedicated to equine health care.

“Globally, Boehringer Ingelheim is committed to other sustainability practices such as the BE GREEN – Future by Choice program which encompasses water management, renewable energy use and overall energy consumption,” McAvoy said. “We are thrilled that the equine team in the United States can align with this global commitment.”

“The Aservo Equihaler recycling program is a great example of a targeted waste stream that has enormous potential to do great things for both animal health and sustainability in the veterinary industry,” said Tom Szaky, CEO and founder of TerraCycle. “TerraCycle’s partnership with Boehringer Ingelheim marks an exciting opportunity to engage horse enthusiasts, animal lovers and veterinarians with sustainability in a way that has never been done before.”

The Aservo Equihaler Retraining Program is open to any interested horse owner or veterinary practice.

ASERVO EQUIHALER IMPORTANT SAFETY INFORMATION: Aservo Equihaler has not been evaluated in pregnant or lactating mares. In a large clinical field study, the most frequently reported side effects were cough, runny nose, sneezing and nasal irritation/bleeding. Do not use in humans. Keep this and all medicines out of the reach of children.

About Boehringer Ingelheim Animal Health USA

Boehringer Ingelheim Animal Health is working on breakthrough innovation for the prediction, prevention and treatment of disease in animals. For veterinarians, pet owners, producers and governments in over 150 countries, we offer a broad, innovative portfolio of products and services to improve the health and well-being of pets and livestock. .

As a global leader in the animal health industry and part of the family business Boehringer Ingelheim, we take a long-term view. The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are also healthier. By utilizing the synergies between our Animal Health and Human Pharma businesses and delivering value through innovation, we improve the health and well-being of both.

Boehringer Ingelheim Animal Health has deep roots in the USA From its beginnings in St. Joseph, Missouri more than 100 years ago, it has grown to encompass seven locations. The Boehringer Ingelheim Animal Health portfolio contains widely used and respected vaccines, pest control products and therapeutics for companion animals, horses and livestock, including NexGard®, Heartgard®, Pyramid®+ Presponse®, VAXXITEK, CircoFLEX ® and Prascend®.

Learn more about Boehringer Ingelheim Animal Health USA at https://bi-animalhealth.com/.

About TerraCycle

TerraCycle is an innovative waste management company on a mission to eliminate the idea of ​​waste. Operating nationwide in 21 countries, TerraCycle partners with leading consumer products companies, retailers and cities to recycle products and packaging, from dirty diapers to cigarette butts, that would otherwise end up be buried or incinerated. Additionally, TerraCycle works with leading consumer product companies to integrate hard-to-recycle waste streams, such as ocean plastic, into their products and packaging. Its new division, Loop, is the first shopping system that gives consumers a way to buy their favorite brands in durable, reusable packaging. TerraCycle has won over 200 sustainability awards and donated over $44 million to schools and charities since its inception over 15 years ago and was named #10 in the list of 52 Companies Changing the World from Fortune magazine. To learn more about TerraCycle or get involved in its recycling programs, please visit https://www.terracycle.com/en-US/.

About Margie Peters

Check Also

Will major new FDA legislation include an expedited approval process?

US lawmakers are under pressure this month to decide whether to make reforms to the …